These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors. Bian XW; Shi JQ; Liu FX Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296 [TBL] [Abstract][Full Text] [Related]
3. p53 protein and epidermal growth factor receptor expression in human astrocytomas. Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240 [TBL] [Abstract][Full Text] [Related]
4. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Astrocytic Tumors in Iraqi Patients. Abdulghani MM; Abbas MN; Mohammed WR Open Access Maced J Med Sci; 2019 Nov; 7(21):3514-3520. PubMed ID: 32010368 [TBL] [Abstract][Full Text] [Related]
6. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Agosti RM; Leuthold M; Gullick WJ; Yasargil MG; Wiestler OD Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):321-5. PubMed ID: 1314448 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas. Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in pediatric high-grade astrocytomas. Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506 [TBL] [Abstract][Full Text] [Related]
9. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression? Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324 [TBL] [Abstract][Full Text] [Related]
10. AgNOR- and PCNA-studies in astrocytomas of the optic nerve. Patt S; Giraldo M; Martin H Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678 [TBL] [Abstract][Full Text] [Related]
11. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index]. Xu QZ; Liu F; Lu DH; Yu SZ; Yang H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073 [TBL] [Abstract][Full Text] [Related]
12. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study. Klein R; Roggendorf W Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624 [TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptors and c-erbB-2 proteins in human astrocytic tumors. Hwang SL; Chai CY; Lin HJ; Howng SL Kaohsiung J Med Sci; 1997 Jul; 13(7):417-24. PubMed ID: 9260461 [TBL] [Abstract][Full Text] [Related]
14. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance. Kirkegaard LJ; DeRose PB; Yao B; Cohen C Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of proliferating cell nuclear antigen and epidermal growth factor receptor expression in glial tumours: correlation with histological grading. Mottolese M; Natali PG; Coli A; Bigotti G; Benevolo M; Cione A; Raus L; Carapella CM Anticancer Res; 1998; 18(3B):1951-6. PubMed ID: 9677449 [TBL] [Abstract][Full Text] [Related]
16. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related]
17. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167 [TBL] [Abstract][Full Text] [Related]
18. Expression of p53-protein, epidermal growth factor receptor (EGFR) and proliferating cell antigens in human gliomas. Kordek R; Bratosiewicz J; Biernat W; Alwasiak J; Liberski PP Folia Neuropathol; 1994; 32(4):227-8. PubMed ID: 7889334 [TBL] [Abstract][Full Text] [Related]
19. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
20. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status. Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]